What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?

Do you find it helpful to monitor for treatment response, resolution, and/or recurrence?

Answer from: at Community Practice

Beta-hydroxybutyrate (BOHB) ≥3.0 mmol/L is highly sensitive and specific for diagnosing DKA and can be measured through serum or point-of-care testing. However, its role in monitoring treatment response and determining resolution remains debated. The American Diabetes Association recommends conti...

Comments

at Uchealth Endocrinology Clinic Steamboat Springs
I agree with Dr. @Sankey. I am an endocrinology fe...

at Temple University Hospital
Is there any scenario where BHB monitoring is nece...

at NYU Langone Pulmonary Associates
I have never looked at a BHB after the initial one...

Please select the option that best describes you:

What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?

Related Questions